These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8495252)

  • 21. [Immunosuppressive drugs in rheumatic diseases (author's transl)].
    Gerster JC; Fallet GH
    Ther Umsch; 1979 May; 36(5):443-9. PubMed ID: 451957
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunosuppression and rheumatoid arthritis.
    Roberts SD
    Ir Med J; 1975 Jun; Suppl():21-8. PubMed ID: 1181323
    [No Abstract]   [Full Text] [Related]  

  • 23. The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis.
    Urowitz MB; Lee P
    Baillieres Clin Rheumatol; 1990 Aug; 4(2):193-206. PubMed ID: 2032296
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical use of immunosuppressive drugs.
    Forbes IJ
    Med J Aust; 1973 Apr; 1(15):749-52. PubMed ID: 4707372
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytotoxic treatment of chronic joint diseases].
    Prat A; Gascon J
    Union Med Can; 1976 Apr; 105(4):599-603. PubMed ID: 997012
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of chronic diseases of connective tissue by cytostatic drugs].
    Deicher H; Fricke R; Kruli P
    Rev Clin Esp; 1970 Mar; 116(6):539-48. PubMed ID: 4996836
    [No Abstract]   [Full Text] [Related]  

  • 27. [Positive and negative effects of cytostatic therapy in rheumatic patients].
    Krampac I
    Reumatizam; 1970; 17(2):51-4. PubMed ID: 5311483
    [No Abstract]   [Full Text] [Related]  

  • 28. Relative macrocytosis in cyclophosphamide and azathioprine therapy.
    Klippel JH; Decker JL
    JAMA; 1974 Jul; 229(2):180-1. PubMed ID: 4406826
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study].
    Westedt ML; Dijkmans BA; Hermans J
    Rev Rhum Ed Fr; 1994 Oct; 61(9):591-7. PubMed ID: 7858592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hematologic controls of the course of immunosuppressive therapy in rheumatic diseases].
    Heidelmann G; Fleischer J; Schwenke R
    Z Gesamte Inn Med; 1970 Aug; 25(15):718-20. PubMed ID: 5527536
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis.
    Sherrer Y; Bloch D; Strober S; Fries J
    J Rheumatol; 1987 Feb; 14(1):46-51. PubMed ID: 3572934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytotoxic drugs in treatment of nonmalignant diseases.
    Ann Intern Med; 1972 Apr; 76(4):619-42. PubMed ID: 4268240
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunosuppressive treatment in rheumatoid arthritis].
    Parrow A
    Nord Med; 1971 Jul; 86(27):835. PubMed ID: 5558475
    [No Abstract]   [Full Text] [Related]  

  • 35. [The place of cytostatics in the treatment of rheumatoid arthritis].
    Ivan Stojanović I
    Reumatizam; 1978; 25(1):2-5. PubMed ID: 644151
    [No Abstract]   [Full Text] [Related]  

  • 36. [A comparative evaluation of the treatment results with cyclosporin A, methotrexate and azathioprine in rheumatoid arthritis patients (a preliminary report)].
    Usova SB; Sigidin IaA
    Ter Arkh; 1993; 65(5):65-9. PubMed ID: 8036601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders.
    Nashel DJ
    Med Clin North Am; 1985 Jul; 69(4):817-40. PubMed ID: 3903379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.
    Currey HL; Harris J; Mason RM; Woodland J; Beveridge T; Roberts CJ; Vere DW; Dixon AS; Davies J; Owen-Smith B
    Br Med J; 1974 Sep; 3(5934):763-6. PubMed ID: 4606370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of immunosuppressive drugs in rheumatic diseases.
    Steinberg AD
    Arthritis Rheum; 1973; 16(1):92-6. PubMed ID: 4540291
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.